1. Shen X, Lee K, König R. Effects of heavy metal ions on resting and antigenactivated CD4(+) T cells. Toxicology 2001;169:67-80. doi: 10.1016/S0300-483X(01)00483-810.1016/S0300-483X(01)00483-8Open DOISearch in Google Scholar

2. Metryka E, Chibowska K, Gutowska I, Falkowska A, Kupnicka P, Barczak K, Chlubek D, Baranowska-Bosiacka I. Lead (Pb) Exposure enhances expression of factors associated with inflammation Int J Mol Sci 2018;19:1813. doi: 10.3390/ijms1906181310.3390/ijms1906181329925772603240929925772Open DOISearch in Google Scholar

3. Mrowicki J, Mrowicka M, Dziki A, Dziki L, Majsterek I. Etiopathogenesis of inflammatory bowel diseases. Biomark J 2018;4:8. doi: 10.21767/2472-1646.10004610.21767/2472-1646.100046Open DOISearch in Google Scholar

4. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38. doi: 10.1016/j.jacc.2009.09.00910.1016/j.jacc.2009.09.009283416919942084Open DOISearch in Google Scholar

5. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47(Suppl):C7-C12. doi: 10.1016/j.jacc.2005.09.06810.1016/j.jacc.2005.09.06816631513Open DOISearch in Google Scholar

6. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-81. doi: 10.1152/physrev.00024.200510.1152/physrev.00024.200516601268Open DOISearch in Google Scholar

7. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:369-77. doi: 10.1056/NEJM19760812295070710.1056/NEJM197608122950707819830Open DOISearch in Google Scholar

8. Boulay JL, O’Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003;19:159-63. doi: 10.1016/S1074-7613(03)00211-51293234910.1016/S1074-7613(03)00211-5Search in Google Scholar

9. Navas-Acien A, Guallar E, Silbergeld E, Rothenberg SJ. Lead exposure and cardiovascular disease: a systematic review. Environ Health Perspect 2006;115:472-82. doi: 10.1289/ehp.978510.1289/ehp.9785184994817431501Open DOISearch in Google Scholar

10. Aoki Y, Brody DJ, Flegal KM, Fakhouri TH, Parker JD, Axelrad DA. Blood lead and other metal biomarkers as risk factors for cardiovascular disease mortality. Medicine (Baltimore) 2016;95:e2223. doi: 10.1097/MD.000000000000222310.1097/MD.0000000000002223470624926735529Search in Google Scholar

11. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med 2002;162:2443-9. doi: 10.1001/archinte.162.21.244310.1001/archinte.162.21.244312437403Open DOISearch in Google Scholar

12. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. Blood lead below 0.48 μmol/L (10 μg/dL) and mortality among US adults. Circulation 2006;114:1388-94. doi: 10.1161/CIRCULATIONAHA.106.62832110.1161/CIRCULATIONAHA.106.628321Search in Google Scholar

13. Lanphear BP, Rausch S, Auinger P, Allen RW, Hornung RW. Low-level lead exposure and mortality in US adults: a population-based cohort study. Lancet Public Health 2018;3:e177-84. doi: 10.1016/S2468-2667(18)30025-210.1016/S2468-2667(18)30025-2Open DOISearch in Google Scholar

14. Krocova Z, Macela A, Kroca M, Hernychova L. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol In Vitro 2000;14:33-40. doi: 10.1016/S0887-2333(99)00089-210.1016/S0887-2333(99)00089-2Open DOISearch in Google Scholar

15. Flohé SB, Brüggemann J, Herder C, Goebel C, Kolb H. Enhanced proinflammatory response to endotoxin after priming of macrophages with lead ions. J Leukoc Biol 2002;71:417-24. doi: 10.1189/jlb.71.3.41710.1189/jlb.71.3.417Open DOISearch in Google Scholar

16. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesion. Circ Res 2000;87:153-9. doi: 10.1161/01.RES.87.2.15310.1161/01.RES.87.2.153Open DOISearch in Google Scholar

17. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connely PW, Milstone DS. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255-62. doi: 10.1172/JCI1187110.1172/JCI11871Open DOISearch in Google Scholar

18. Rapisarda V, Ledda C, Ferrante M, Fiore M, Cocuzza S, Bracci M, Fenga C. Blood pressure and occupational exposure to noise and lead (Pb): A cross-sectional study. Toxicol Ind Health 2016;32:1729-36. doi : 10.1177/074823371557661610.1177/0748233715576616Open DOISearch in Google Scholar

19. Yücesoy B, Turhan A, Üre M, Imir T, Karakaya A. Effects of occupational lead and cadmium exposure on some immunoregulatory cytokine levels in man. Toxicology 1997;21;123:143-7. doi: 10.1016/S0300-483X(97)00107-810.1016/S0300-483X(97)00107-8Open DOISearch in Google Scholar

20. Machoń-Grecka A, Dobrakowski M, Kasperczyk A, Birkner E, Pryzwan T, Kasperczyk S. The effect of subacute lead exposure on selected blood inflammatory biomarkers and angiogenetic factors. J Occup Health 2018;60:369-75. doi: 10.1539/joh.2017-0307-OA10.1539/joh.2017-0307-OA617602830122729Open DOISearch in Google Scholar

21. Chmurzyńska A. The multigene family of fatty acid-binding proteins: function, structure and polymorphism. J Appl Genet 2006;47:39-48. doi: 10.1007/BF0319459710.1007/BF0319459716424607Open DOISearch in Google Scholar

22. Başar O, Akbal E, Köklü S, Tuna Y, Koçak E, Başar N, Tok D, Erbiş H, Senes M. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. Herz 2013;38:417-22. doi: 10.1007/s00059-012-3714-x10.1007/s00059-012-3714-x23324907Open DOISearch in Google Scholar

23. Beysel S, Kizilgul M, Ozbek M, Çalışkan M, Kan S, Apaydın M, Ozcelik O, Cakal E. Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease. Clin Interv Aging 2017;12:2063-8. doi: 10.2147/CIA.S13724710.2147/CIA.S137247572200629255351Search in Google Scholar

24. Centers for Disease Control and Prevention (CDC). Blood Lead Levels---United States, 1999--2002. MMWR. May 27, 2005; 54(20):513-516.Search in Google Scholar

25. ACGIH® Threshold Limit Values (TLVs®) and Biological Exposure Indices (BEIs®). Appendix B, 2012. [displayed 28 January 2019]. Available at in Google Scholar

26. Aliyev V, Kayaalti Z, Kaplan B, SoylemezogluT. Effect of GST polymorphisms on as levels of placental and maternal biological samples. Toxicol Lett 2012;211:S43-S216. doi: 10.1016/j.toxlet.2012.03.26110.1016/j.toxlet.2012.03.261Open DOISearch in Google Scholar

27. Valentino M, Rapisarda V, Santarelli L, Bracci M, Scorcelletti M, Di Lorenzo L, Cassano F, Soleo L. Effect of lead on the levels of some immunoregulatory cytokines in occupationally exposed workers. Hum Exp Toxicol 2007;26:551-6. doi: 10.1177/096032710707381710.1177/096032710707381717884957Open DOISearch in Google Scholar

28. Kasperczyk A, Dobrakowski M, Czuba ZP, Horak S, Kasperczyk S. Environmental exposure to lead induces oxidative stress and modulates the function of the antioxidant defense system and the immune system in the semen of males with normal semen profile. Toxicol Appl Pharmacol 2015;284:339-44. doi: 1016/j.taap.2015.03.00110.1016/j.taap.2015.03.00125771126Search in Google Scholar

29. Karbek B, Ozbek M, Bozkurt NC, Ginis Z, Gungunes A, Unsal IO, Cakal E, Delibası T. Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with arterial ıntima-media thickness and role as diagnostic marker for atherosclerosis in patients with impaired glucose metabolism. Cardiovasc Diabetol 2011;10:37. doi: 10.1186/1475-2840-10-3710.1186/1475-2840-10-37311239121535886Open DOISearch in Google Scholar

30. Tanaka T, Sohmiya KI, Kitaura Y, Takeshita H, Morita H, Ohkaru Y, Asayama K, Kimura H. Clinical evaluation of point-of-care-testing of heart-type fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. J Immunoassay Immunochem 2006;27:225-38. doi: 10.1080/1532181060073491910.1080/1532181060073491916827225Open DOISearch in Google Scholar

31. Jeong JH, Seo JH, Ahn JY, Kim KH, Seo JY, Kim MJ, Lee HT, Park PW. The prognostic value of serum levels of heart-type fatty acid binding protein and high sensitivity C reactive protein in patients with increased levels of amino-terminal pro-B type natriuretic peptide. Ann Lab Med 2016;36:420-6. doi: 10.3343/alm.2016.36.5.42010.3343/alm.2016.36.5.420494048427374706Open DOISearch in Google Scholar

32. Davies MJ, Gordon JL, Gearing AJH, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM- 1, VCAM- 1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9. doi: 10.1002/path.171171031110.1002/path.17117103117506307Open DOISearch in Google Scholar

33. Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R. 18F-4V for PET–CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging 2009;2:1213-22. doi: 10.1016/j.jcmg.2009.04.01610.1016/j.jcmg.2009.04.016277312919833312Open DOISearch in Google Scholar

34. Johnston-Cox HA, Koupenova M, Ravid K. A2 adenosine receptors and vascular pathologies. Arterioscler Thromb Vasc Biol 2012;32:870-8. doi: 10.1161/ATVBAHA.112.24618110.1161/ATVBAHA.112.246181575535922423039Search in Google Scholar

35. Futterman LG, Lemberg L. Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A. Am J Crit Care 2002;11:168-72. PMID: 1969064210.4037/ajcc2002.11.2.168Search in Google Scholar

36. Cung H, Aragon MJ, Zychowski K, Anderson JR, Nawarskas J, Roldan C, Sood A, Qualls C, Campen MJ. Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients. J Transl Med 2015;13:99. doi: 10.1186/s12967-015-0457-510.1186/s12967-015-0457-5437634725890092Open DOISearch in Google Scholar

English, Slovenian
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Basic Medical Science, other